Pronto Raises USD 2 Mn from Bain Capital to Scale Rapid Home Services
The funds will be deployed to expand operations, grow the team, and launch in newer cities as the company ramps up its rapid home services model.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Delhi NCR-based home services startup Pronto has raised USD 2 million in a seed funding round from Bain Capital, valuing the company at USD 12.5 million.
The funds will be deployed to expand operations, grow the team, and launch in newer cities as the company ramps up its rapid home services model.
Founded in October 2024 by Anjali Sardana, a BS Biology graduate and former investor at Bain Capital and 8VC, Pronto enables users to book cleaning, laundry, and domestic help services within 10 minutes. The startup assigns professionals for tasks like dishwashing, mopping, and clothes washing, riding the quick commerce wave pioneered by Blinkit, Zepto, and Swiggy Instamart.
"We are on a mission to create two million jobs in two years. We're growing hyper fast and scaling our team rapidly to meet demand," said Sardana. "Building in a tough, often misunderstood space isn't easy. But we've stayed focused on what matters—earning trust, delivering value, and scaling responsibly. Grateful for Bain Capital Ventures' belief in our mission to transform domestic work in India," she added in a LinkedIn post.
Pronto's funding comes just weeks after its direct competitor Snabbit raised USD 5.5 million in a Series A round led by Elevation Capital and Nexus Venture Partners. Both startups are taking on the likes of IPO-bound Urban Company by offering faster, tech-enabled alternatives for household chores.
While some users remain skeptical of the need for instant domestic services, investor confidence in quick commerce remains strong. Since 2021, India has seen a surge in startups innovating around rapid service delivery—from groceries to fashion. While Pronto and Snabbit tackle home services, others like Slikk are reimagining fast fashion, showing the broader potential of India's quick commerce ecosystem.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
31 minutes ago
- Forbes
Circle Soars In First-Ever Stablecoin IPO, Making CEO A Billionaire
Jeremy Allaire, CEO of Circle, at the Token2049 conference in Singapore in Sept. 2024. Photographer: Suhaimi Abdullah/Bloomberg Circle, the company behind the $61 billion stablecoin USDC, made a roaring debut on the New York Stock Exchange Thursday, becoming the first stablecoin issuer to go public and making CEO and cofounder Jeremy Allaire a billionaire. Shares surged as much as 235% after Circle and some of its shareholders raised nearly $1.1 billion in an initial public offering that was upsized twice amid heavy investor demand. The stock opened at $69.50, more than double its IPO price of $31, and climbed as high as $103.75. The offering included 34 million shares from Circle and other shareholders including Allaire, up from the 32 million shares announced earlier this week and 24 million initially. The IPO was priced well above its initial $24–$26 range and even its revised $27–$28. Based on Circle's 2 P.M. stock price of $86, Forbes figures Allaire has a net worth of at least $1.7 billion. BlackRock, already an investor, and Cathie Wood's ARK Investment Management, were among the reported buyers. The deal was led by JPMorgan Chase, Citigroup and Goldman Sachs, alongside 12 other underwriters. 'We're thrilled with the demand,' Circle CFO Jeremy Fox-Geen told Forbes. 'We saw a wide range of investor interest from traditional mutual fund complexes through to high-conviction, long-oriented pools of private capital within the broader hedge fund space, as well as various sovereign wealth funds. I think it says that the investor community is understanding that we are on the precipice of what we here call the new internet financial system.' Circle's listing arguably marks crypto's most significant public market event since Coinbase's 2021 IPO. The New York-based firm is a pure-play stablecoin business: USDC is the world's second-largest stablecoin, making up 27% of the market behind Tether's 67%. While originally used for crypto trading, stablecoins are increasingly drawing attention from financial giants and tech firms—among them Fidelity Investments, Bank of America and Meta—as rails for payments and cross-border transactions. Since launching USDC in 2018, Circle has processed over $25 trillion in transaction volume, nearly $6 trillion of which occurred in just the first quarter of 2025. The company has long positioned itself as the regulated, transparent alternative to Tether, publishing detailed reserve disclosures. In 2024, Circle reported $1.68 billion in revenue and $156 million in net income, up from $1.45 billion in revenue and $268 million in profit the year prior. But its business remains highly concentrated: More than 99% of revenue came from interest income on the cash and Treasurys backing USDC. In its S-1 filing, Circle warned that a 1% drop in interest rates could wipe out $441 million of that revenue. Fox-Geen says diversification is underway: 'We have a set of product investments which we have started monetizing recently, which range from subscription and services revenues, such as our blockchain network partnerships, through to transaction revenues, where we monetize certain of the flows across the network where users of the network wish to use a value added service which they're willing to pay for.' Those initiatives generated $20.7 million in Q1. Modest for now, but growing quickly, he noted. The company's distribution model, however, remains costly. In 2024, Circle paid over $1 billion in distribution fees—$900 million of it to Coinbase. Tether, by contrast, doesn't pay distributors to maintain dominance. The road to public markets was not a straight one. Circle scrapped a $9 billion SPAC merger in late 2022. In 2023, the company was hit by the collapse of Silicon Valley Bank, where it had deposited a portion of its reserves. Though Circle ultimately recovered the funds, USDC's market capitalization took months to rebound. In April, Circle reportedly fielded acquisition offers from both Coinbase and Ripple valuing the company at around $5 billion. It opted instead to go public, filing confidentially for an IPO early this year. It's likely a bet that regulatory clarity will finally be arriving, and with it, a premium for compliance. 'Becoming public has always been part of our strategy,' said Fox-Geen. 'This is a multi decade transformation of the plumbing of the financial services industry, but that understates just how profound a technology upgrade this really is.'
Gizmodo
37 minutes ago
- Gizmodo
PlayStation's Big Plan to Defy the Switch 2 Is a Wireless Fight Stick for PS5 and PC
Sony's in a strange state now that the Switch 2 has finally seen the light of day. In an effort to claw back some of the spotlight, PlayStation declared it's making its first wireless fight stick, called 'Project Defiant.' At first glance, the controller seems like a solid option for fighting game fanatics. The main issue is that Sony is holding it back for an entire year. Project Defiant, a name that seems a little too on the nose considering the other big gaming hardware hitting the scene today, is a full-on fight stick complete with the typical PlayStation-centric layout you know from the DualSense controller. It's a device made with the hardcore fighting game player in mind. The pad has toolless interchangeable restrictor gates that sit inside a compartment whenever you need them. Restrictor gates sit underneath the stick to create a physical sense of the stick's orientation. PlayStation's new controller supports the Japanese-style square restrictor gate as well as a circle and octagon. The buttons are built on mechanical switches, which should hopefully offer a tactile feel. Project Defiant is still a PlayStation controller, and you can access touchpad functions along the top of the controller. Sony's stark black and white design lends itself well to the typical fighting stick design, especially the glowing LED accent where the pane with the stick meets the raised button panel. Like its more recent headsets, the controller uses Sony's own PlayStation Link for low-latency connectivity, which means you'll need to use a special USB dongle. Sony says Project Defiant should be compatible with both PS5 and PC, but if you want to avoid the dongle, you can connect it via USB-C. The controller even includes its own carrying case. So you're probably wondering how much it costs or when you can get one. Unfortunately, Sony hasn't revealed anything about release timing beyond a planned launch in 2026. The company does tend to reveal peripherals months before launch, even before offering the device's official names, like Sony's 'Project Q' which eventually became the PlayStation Portal. There were only three months between the reveal of Sony's odd streaming handheld and its launch. Sony is hankering to claw as much spotlight away from Nintendo's Switch 2. The technology giant dropped trailers for a few key games at its latest PlayStation State of Play, though videos for big games like Ghost of Yōtei and Metal Gear Solid: Delta didn't include much to chew on. Yōtei was merely a teaser trailer for yet another State of Play set to debut in July. The more landmark announcements, like the new trailer for IO Interactive's 007: First Light alongside more footage of Silent Hill F. At the very least, the return of Final Fantasy Tactics with the new title The Ivalice Chronicles built up some buzz from longtime fans. We'll have to wait and see if there will be any more gaming hardware news that can burst the Switch 2's hype bubble. Sony is reportedly working on a handheld to rival the Switch or Steam Deck, but it has yet to materialize beyond rumors. We're still waiting to see if the Xbox-branded Asus gaming handheld can take our eyes away from either Nintendo's or Valve's latest devices. Last week, Windows Central reported Microsoft reportedly sidelined its own Xbox handheld so it could work on a version of Windows 11 made for handheld form factors.
Yahoo
43 minutes ago
- Yahoo
Kailera Therapeutics Appoints Adam Koppel and Christopher Hite to Board of Directors
BOSTON and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions, today announced the appointments of Adam Koppel and Christopher Hite to its Board of Directors. 'We are thrilled to welcome Adam and Chris to our Board of Directors. Their extensive track records as respected advisors to biopharma companies on corporate and financial strategy will be incredibly valuable as we continue to execute on our mission to advance next-generation therapies for the treatment of obesity,' said Ron Renaud, President and Chief Executive Officer, Kailera. 'It's an exciting time to join Kailera's Board as they progress their pipeline toward late-stage global trials, and I look forward to contributing to the company's continued success and long-term value creation,' said Dr. Koppel. Mr. Hite added, 'I am pleased to join the Board of Kailera at this important time of innovation in the obesity space that has positively impacted millions of patients worldwide. Kailera has a clear strategy to advance their diversified pipeline, and I look forward to supporting the leadership team as they work towards achieving their mission.' Dr. Koppel is a distinguished investor and strategic leader with more than 25 years of biopharmaceutical industry experience. He is a Partner on Bain Capital's Life Sciences team and initially joined Bain Capital in 2003. Previously, Dr. Koppel was EVP of Corporate Development and Chief Strategy Officer at Biogen. He currently sits on the Board of Directors of Areteia Therapeutics and Cardurion Pharmaceuticals and serves on the Board of Trustees at Newton Wellesley Hospital. Dr. Koppel also co-chairs the Harvard Medical School Discovery Council and serves on the Mass General Brigham Innovation Growth Board. He received an M.D. and Ph.D. in Neuroscience from the University of Pennsylvania School of Medicine. Dr. Koppel also received an M.B.A. from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar, and graduated magna cum laude from Harvard University with an A.B. and A.M. in History and Science. Mr. Hite, a seasoned financial executive with over 25 years of financial and strategic experience in the biopharmaceutical industry, will serve as an independent board member and audit committee chair. Mr. Hite currently serves as Executive Vice President and Vice Chairman at Royalty Pharma. Prior to joining Royalty Pharma in 2020, he was at Citibank for over a decade, serving most recently as Vice Chairman of Banking, Capital Markets and Advisory (BCMA) and a member of the BCMA Executive Committee, and previously as the Global Head of Healthcare Investment Banking. Prior to joining Citibank, Mr. Hite was the Global Head of Healthcare Investment Banking at Lehman Brothers. He serves on the Board of Trustees at Lehigh University, the Board of Advisors of Faster Cures, a center of the Milken Institute, and served on the Board of Directors of Acceleron Pharma Inc. until its acquisition by Merck in November 2021. Mr. Hite has a B.S. from Lehigh University, and a J.D. and M.B.A. from the University of Pittsburgh. About Kailera Therapeutics Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity and related conditions. Kailera's most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that has demonstrated positive results in Phase 2 trials in obesity and type 2 diabetes in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery, including oral administration. Kailera's mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health. The Company is based in Waltham, MA and San Diego, CA. For more information, visit and follow us on LinkedIn and X. Contact Information Maura Gavaghan Vice President, Corporate Communications and Investor Relations while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
